Physician

Adam Leroy, M.D.

According to 2025 Medicare claims, Adam Leroy, M.D. (NPI: 1922021542) practices family practice in the North Port-Bradenton-Sarasota, FL market, with the plurality of this provider's patient population coming from Manatee, FL. This provider's primary affiliated billing organization is ALDRICH CARDIOVASCULAR INSTITUTE (NPI: 1184614851; TIN: 20-1729166) and primary practice location at 34202-5177. Leroy is affiliated with the PBACO Holding, LLC (ACO ID: A1001), participating under the MSSP model.

Leroy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 516 traditional Medicare patients, billed 3,076 HCPCS/CPT codes, and received $148,707 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 16,584 prescription claims across 1,223 beneficiaries totaling $1,938,437 in drug costs, led by Ozempic (Semaglutide). DME data shows 100 claims. Open Payments data shows 99 records totaling $1,835. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $56,818 to $148,707. Similarly, Part D prescription costs have moved sharply higher in recent years, from $11,948 to $1,938,437. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	338	500	$56,818
2016	352	520	$56,737
2017	312	473	$47,591
2018	689	1,067	$89,927
2019	903	1,367	$115,020
2020	862	1,278	$108,485
2021	488	2,013	$156,872
2022	507	2,009	$154,027
2023	512	3,367	$167,932
2024	516	3,076	$148,707

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	349	624	$11,948
2016	353	707	$8,874
2017	262	450	$8,083
2018	250	367	$7,027
2019	370	562	$6,819
2020	447	687	$10,713
2021	892	10,308	$911,732
2022	970	13,151	$1,348,639
2023	1,117	14,783	$1,637,661
2024	1,223	16,584	$1,938,437

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	16	35	$517
2022	14	46	$455
2023	15	105	$5,246
2024	11	100	$14,532

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	307	307	$126
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	340	582	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	192	284	$61
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	325	563	$12
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	65	74	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	218	11,750	$368,470
Eliquis	Apixaban	267	16,763	$313,796
Jardiance	Empagliflozin	135	8,454	$162,291
Xarelto	Rivaroxaban	62	5,134	$93,742
Glyxambi	Empagliflozin/Linagliptin	63	4,430	$85,176

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	18	$10,256
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	12	$1,041
B4150	Enteral formula, nutritionally complete with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	12	$1,008
B4034	Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	11	$897
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	13	$817

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	99	$1,835	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Leroy, M.D.?

Tedicare shows public-source Medicare data for Adam Leroy, M.D. (NPI 1922021542), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Leroy, M.D. have ACO affiliation data?

Adam Leroy, M.D. is shown with ACO affiliation data for PBACO Holding, LLC (MSSP, ACO ID A1001).

What billing organization is linked to Adam Leroy, M.D.?

Adam Leroy, M.D. is linked to ALDRICH CARDIOVASCULAR INSTITUTE (billing NPI 1184614851) in the available physician profile data.

Does Adam Leroy, M.D. have Open Payments data?

Adam Leroy, M.D. has 99 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.